Bitcoin regains some lost ground

span.p-content div[id^=div-gpt] { line-height: 0px; font-size: 0px;} After reaching $4,960 a fortnight ago, the bitcoin’s price nosedived to the $3,000 level last Friday when one Chinese exchange said it was closing its operations. The move followed the Chinese authorities’ decision to ban initial coin offerings, something like initial public offerings (IPOs) for shares.  However, on Tuesday, the was back above […]

Apple revamps its App Store

span.p-content div[id^=div-gpt] { line-height: 0px; font-size: 0px;} Apple’s newest operating system for iPhones and iPads introduces changes to its marketplace for third-party software to satisfy app developers and add new so-called augmented reality apps.   The system, called iOS 11, is being released on Tuesday ahead of its two newest phone handsets, the and iPhone X, set to start shipping […]

Battling wilful defaulters

span.p-content div[id^=div-gpt] { line-height: 0px; font-size: 0px;} and (FIs) have been hit hard by defaulting borrowers, especially corporate houses and firms, facing a number of woes. Many have failed to pay because of a sharp dip in revenues and businesses going bust. In view of this, some keep defaulting despite their ability to pay. They are, hence, termed wilful defaulters. […]

Agrichem firms in the south better placed

span.p-content div[id^=div-gpt] { line-height: 0px; font-size: 0px;} The profitability of agrochemicals companies that have operations in is likely to stay better than those of industry peers in the current financial year, following a recovery in sales after a weak June quarter. While all companies in the agrochemicals space faced destocking problems in the June quarter ahead of the introduction of […]

Launches bring little cheer for Cadila

Cadila Healthcare recently got an approval for generic version of Tamiflu, a medication used in treating influenza (flu). It is the first generics player to get an approval for the drug with sales of $367 million, for trailing 12 months ended July, according to industry body IMS. Analysts expect Lupin and Natco, too, to get the go ahead. This is […]